Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Meir Medical Center
Age
50–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subject is 50 years old and above
Subject is asymptomatic and referred for regular recommended screening colonoscopy or subject is referred due to suspicion of colon cancer, prior to beginning of any treatment (enriched population)
Subject signed the informed consent
You may not be if
Subject has been previously diagnosed with any type of cancer
Subject has been previously diagnosed with a colorectal abnormality such as colorectal adenoma, hyperplastic polyp or carcinoma
Blood sample was not collected on the day of colonoscopy and prior to colonoscopy
Subject has first degree family history of colorectal cancer
Subject has active infection or inflammation as determined clinically at screening
Subject has participated in, or is participating in, any investigational drug or device study within 30 days prior the date of colonoscopy and any additional study required test
Pregnant or lactating woman
Clareo Health | Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay
